---
figid: PMC8581318__JCMM-25-10684-g002
figtitle: SC66 inhibits the proliferation and induces apoptosis of human bladder cancer
  cells by targeting the AKT/B‐catenin pathway
organisms:
- Homo sapiens
- Mus musculus
- Armoracia rusticana
pmcid: PMC8581318
filename: JCMM-25-10684-g002.jpg
figlink: /pmc/articles/PMC8581318/figure/jcmm17005-fig-0010/
number: F10
caption: The schematic diagram explains the molecular mechanism of SC66's anti‐cancer
  effect. In short, SC66 regulates the expression of downstream target genes through
  the AKT/GSK‐3β/β‐catenin signalling pathway to inhibit the proliferation, migration,
  invasion of BC cells and induce apoptosis
papertitle: SC66 inhibits the proliferation and induces apoptosis of human bladder
  cancer cells by targeting the AKT/β‐catenin pathway.
reftext: Wu Chen, et al. J Cell Mol Med. 2021 Nov;25(22):10684-10697.
year: '2021'
doi: 10.1111/jcmm.17005
journal_title: Journal of Cellular and Molecular Medicine
journal_nlm_ta: J Cell Mol Med
publisher_name: John Wiley and Sons Inc.
keywords: AKT | apoptosis | bladder cancer | cell cycle | epithelial‐mesenchymal transition
  | SC66 | β‐catenin signalling pathway
automl_pathway: 0.9528029
figid_alias: PMC8581318__F10
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC8581318__F10
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8581318__JCMM-25-10684-g002.html
  '@type': Dataset
  description: The schematic diagram explains the molecular mechanism of SC66's anti‐cancer
    effect. In short, SC66 regulates the expression of downstream target genes through
    the AKT/GSK‐3β/β‐catenin signalling pathway to inhibit the proliferation, migration,
    invasion of BC cells and induce apoptosis
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Ctnnb1
  - Apc
  - Axin1
  - Ccnd1
  - Akt1
  - CTNNB1
  - APC
  - PROC
  - AXIN1
  - AXIN2
  - CCND1
  - AKT1
  - AKT2
  - AKT3
---
